- AI can help predict the potential effectiveness of new drugs and speed up the drug discovery process.
- AI can analyze patient data to create personalized treatment plans based on individual genetic and biological factors.
- AI can help design and optimize clinical trials to make them more efficient and cost-effective.
- AI can analyze patient data to predict and prevent adverse drug events.
- Pharmacovigilance: AI can help monitor and detect adverse drug reactions in real-time, allowing for quicker responses and improved patient safety.
Artificial intelligence (AI) has rapidly transformed many industries, and the pharmaceutical industry is no exception. AI has brought a significant shift in the way pharmacists work and has improved patient outcomes in many ways. In this blog, we will explore how AI is transforming the pharmacy industry.
Tractica expects the worldwide AI software industry to expand from $10.1 billion in 2018 to $126 billion in 2025. The pharmaceutical sector is integrating Big Data and AI technologies in a data-driven world.
How is AI impacts pharmacy?
AI is having a significant impact on the field of pharmacy, revolutionizing many aspects of medication management, patient care, drug discovery, and clinical decision-making. Some of the ways in which AI is impacting pharmacy include:
- Medication management: AI algorithms can assist pharmacists in identifying potential drug interactions and adverse drug reactions, optimizing medication dosages, and monitoring patients’ adherence to their medication regimens.
- Patient care: AI can help patient engagement by pharmacies developing personalized treatment plans based on patients’ unique genetic and physiological characteristics.
- Clinical decision-making: AI algorithms can help pharmacists make informed clinical decisions by providing real-time patient data, drug information, and treatment recommendations.
- Automation: AI-powered robots and machines can streamline pharmacy operations, including medication dispensing, inventory management, and prescription processing, improving efficiency and reducing errors.
Artificial intelligence in the Pharmaceutical Industry: Applications
From drug development and production to marketing, AI may be used in practically every element of the pharmaceutical sector. Pharma firms may optimise all business processes for efficiency, cost-effectiveness, and ease of use by using and integrating AI technology into the fundamental workflows.
The best aspect is that AI systems may be a potent weapon in the research and development wing of the pharmaceutical sector because they are designed to produce better results as they continuously learn from fresh data and experience.
Let’s examine some of the pharmaceutical industry’s top AI implementations that need to be mentioned:
1. To speed up the drug discovery process
R&D Pharma businesses all over the world are utilising cutting-edge ML algorithms and AI-powered solutions. These intelligence technologies can be used to address problems related to intricate biological networks because they are made to find detailed patterns in vast datasets.
This ability is great for examining the patterns of different diseases and identifying the drug formulations that would be most effective for addressing particular characteristics of a given condition. As a result, pharmaceutical companies can spend money on developing treatments that have the best possibility of curing an illness or other medical condition.
2. Drug development
The application of AI has the potential to advance R&D. AI is capable of anything, from developing and detecting new compounds to discovering and validating target-based medications. The development of customized AI based pharmaceutical software that tailors your needs and give your company a competitive edge.
Just 13.8% of medications pass clinical trials successfully, according to an MIT study. Also, a pharmaceutical company must spend anywhere from US$ 161 million to US$ 2 billion for a medicine to successfully complete a clinical trial and receive FDA approval. These are the two key factors driving the growing adoption of AI by the pharmaceutical industry to lower operating costs, increase medicine and therapy affordability, and increase the success rates of new drugs.
Large volumes of patient healthcare data may be collected, processed, and analysed by doctors using cutting-edge machine learning algorithms. Sensitive patient data is being safely stored in the cloud or other centralised storage systems by healthcare providers all over the world utilising ML technology. The term “electronic medical records” refers to this (EMRs).
These records are available for doctors to consult whenever they need to comprehend how a patient’s health may be impacted by a certain genetic trait or how a particular prescription may be used to treat a medical condition. EMR data can be used by machine learning (ML) systems to provide real-time predictions for diagnosis and treatment recommendations to patients.
Millions of lives could be saved if faster diagnosis was possible due to ML technology’ capacity to process and evaluate vast amounts of data quickly.
FDA recently approved the sale of the GI Genius medical device, which uses an AI system and is based on machine learning. Clinicians are now using it to look for indicators of colon cancer. During a colonoscopy, you can quickly identify areas of the colon that may have lesions with the use of this instrument.
4. Prevention of diseases
Pharmaceutical businesses can employ AI to create treatments for both common diseases like Parkinson’s and Alzheimer’s as well as unusual disorders. As the ROI is so poor compared to the time and money required to create pharmaceuticals to treat uncommon diseases, pharmaceutical companies typically do not devote their time and resources to developing cures for rare diseases.
Global Genes estimates that there are no FDA-approved medicines or solutions for roughly 95% of uncommon diseases. Yet, the situation is quickly improving because of the inventive capabilities of AI and ML.
5. Epidemic predictions
Many pharmaceutical businesses and healthcare providers now utilise AI system and ML to track and predict epidemic outbreaks around the world. These technologies draw information from numerous online sources, analyse how diverse geological, environmental, and biological elements affect the health of the people in various regions, and attempt to draw connections between these factors and previous epidemic breakouts. Such AI/ML models are especially beneficial for developing nations without the financial and medical infrastructure needed to handle an epidemic outbreak.
The outbreak prediction of the ML-based Malaria Model, which serves as a warning tool for potential malaria outbreaks and helps healthcare providers determine the best course of action to combat them, is a nice illustration of this AI application.
6. Distance Observation
A innovation in the pharmaceutical and healthcare industries is remote monitoring. Numerous pharmaceutical companies have already created wearables that use AI algorithms to remotely monitor patients with serious illnesses.
For example, many firms worked together to develop AI technology that allows for remote monitoring of patients with Parkinson’s disease and cuts the time needed to do a motor function assessment from 30 minutes to three minutes. It is feasible to see a patient’s hands’ opening and closing gestures from a distance by fusing this AI technology with smartphone apps.
The smartphone camera will record hand movement when it detects it in order to gauge the severity of the Parkinson’s symptoms. The severity score of the patient’s illness will be determined by the frequency and magnitude of the movement, allowing doctors to modify medications and dosages remotely.
The AI will alert the doctor and set up a checkup if the circumstances worsen and call for an upgrade in therapy. These remote arrangements make it unnecessary for patients to return and forth to the doctor’s office, saving them the trouble of travelling and waiting.
AI can be used in the manufacturing process by pharmaceutical businesses to increase productivity, improve efficiency, and hasten the creation of life-saving medications. Each step of the manufacturing process can be managed and enhanced by AI, including:
- quality assurance
- preventing future problems
- waste minimization
- design improvement
- automation of processes
AI can take the role of labor-intensive conventional production methods, enabling pharmaceutical companies to get new pharmaceuticals to the market considerably more quickly and inexpensively. AI would significantly increase their return on investment by reducing the amount of human involvement in the production process, and it would also completely eliminate any room for human error.
Given that the pharmaceutical sector is a sales-driven industry, artificial intelligence (AI) can be a useful tool in pharma marketing. Pharma firms can investigate and create distinctive marketing tactics with AI that promise strong sales and brand recognition.
AI can assist in mapping the customer journey, enabling businesses to see which marketing strategy brought people to their website (lead conversion) and eventually convinced those visitors to make a purchase from them. Pharma businesses can therefore concentrate more on the marketing tactics that provide the highest conversions and revenue growth.
AI systems may evaluate and compare the outcomes of previous marketing campaigns to determine which ones continued to be the most successful. This saves time and money while also enabling businesses to design their current marketing strategies accordingly. AI systems can even anticipate with accuracy the success or failure rate of marketing efforts, in addition.
Despite the fact that the pharma business is quickly adopting AI, the transformation process is not without difficulties. Most pharma businesses’ present IT infrastructure is typically built on antiquated technologies that aren’t AI-optimized.
However, the integration and use of AI require industrial knowledge and expertise, which are still in short supply. But, by implementing the following actions, the adoption of AI in the pharmaceutical industry can be sped up:
working and partnering with academic institutions that are experts in AI R&D to help pharmaceutical businesses implement AI.
Work together with businesses that focus on AI-driven drug discovery to gain access to professional help, cutting-edge equipment, and market knowledge.
For maximum productivity, teach the R&D and manufacturing teams how to properly use and implement AI tools and processes.
9. Medical Compliance And Dosage
Artificial intelligence is being used in pharmacy at a rate that has never been seen before. AI is increasingly being utilised in the pharmaceutical industry to determine the proper dosages of medications to be taken in order to protect drug users. In addition to assisting with patient monitoring throughout clinical trials, it also recommends the proper dosage at regular intervals.
One of the main causes of the rising demand for accuracy in this industry is artificial intelligence, which has sped up the automation of procedures in the pharmaceutical industry. The potential applications of AI in the pharmaceutical industry are immeasurable and guarantee compliance and efficiency. Also, AI in the pharmaceutical industry has opened up a number of possible AI opportunities for workers, many of which have excellent salaries and perks.
Pharmacy’s Future With Artificial Intelligence
According to research, by 2025, nearly half of all healthcare facilities worldwide will have integrated this technology into their daily operations. The use of artificial intelligence in pharmacy is expanding in this way. It is anticipated that drug research companies will increase their investments in this technology in order to find novel treatments for cancer and chronic disorders. Diabetes, cancer, and chronic kidney illnesses are a few of the key chronic diseases that artificial intelligence is predicted to help treat.
By quicker evaluations and the identification of the top candidates for a specific study, AI is also anticipated to enhance the present candidate selection procedures for clinical trials. With the data provided for their patients, experts can use AI to provide more useful information. This also applies to mammograms and MRI pictures. While each of these will undoubtedly alter the healthcare sector as a whole, there is also the added bonus of the abundance of AI employment that will be accessible in the future for professionals in this area. Accessibility to the technology won’t be a problem due to its growing adaptability, and it will gradually integrate into the industrial and pharmaceutical industries as a natural process.
Arkenea, a firm that specialises in the development of software for telehealth, has provided cutting-edge software solutions to its customers for more than 12 years. If you are seeking for telehealth software for your company, you should get in touch with Arkenea.